Recent Achievements at the Berman Cancer Institute

Karen Ulmer Honored for Outstanding Service

Congratulations to Karen Ulmer, MSN, RN, CORLN, for receiving the Outstanding Service Award from the Society of Otorhinolaryngology and Head-Neck Nurses (SOHN). SOHN is the only nursing specialty organization to focus on ENT and Head-Neck conditions. Karen has been a member since 1990, serving in a variety of roles both locally and at the national level. This is just one of several recent achievements by the staff of the Sandra and Malcolm Berman Cancer Institute

Radiation Oncology Introduces Enhancements

Radiation Oncology enhanced the treatment planning systems. Three new modules were added. These additions will allow the department to stay current with the cutting-edge practices in radiation oncology. Jason Judy, CMD, Sr. Dosimetrist, explains that this is needed to produce higher quality, more accurate radiation plans and further reduces the radiation dose to normal, healthy tissue.

Dr. Tutrone Continues as Research Chair

Dr. Ronald F. Tutrone Jr., begins his 15th year as The William E. Kahlert GBMC Chair in Urological Research. This perpetual research endowment was established in 2007 thanks to a generous $3 million donation from the now-late Bill Kahlert, a grateful patient.

At the time the chair was established, Dr. Tutrone said, “The creation of a research chair in urology is groundbreaking at a community hospital and will have far-reaching benefits for patients and our community at large. We are very grateful for this generous gift from Mr. William Kahlert, which will certainly help pave the way for urological research well into the future.”

That future is now. Kahlert allowed GBMC to be at the cutting edge of clinical trials in urology through the organization’s first endowed research chair, which supports the research of prostate, bladder and kidney cancers, as well as other urological conditions. Under Dr. Tutrone’s leadership, research has expanded exponentially and impacted thousands of patients.

As a patient, Kahlert recognized that research trials identify the latest medical interventions and advancements for cancer patients. The results of clinical trials can extend or save patients’ lives as well as contribute to the development of new therapies for the future.